| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.045 | 0.3 |